July 28 is World Hepatitis Day

July 27, 2018

(HealthDay)—July 28 is World Hepatitis Day, according to an announcement published in the July 20 issue of the U.S. Centers for Disease Control and Prevention's Morbidity and Mortality Weekly Report.

The goal of the annual commemoration is to promote awareness and inspire action to prevent and treat viral hepatitis. This year's theme is "Test. Treat. Hepatitis," underscoring the need to scale up testing and treatment activities.

The World Health Organization estimates that globally, in 2015, approximately 325 million persons were infected with hepatitis B or C virus. The World Health Assembly has endorsed elimination goals set by the World Health Organization, defined as a global reduction of incidence by 90 percent and mortality by 65 percent by 2030.

2018 World Hepatitis Day is Saturday, July 28.

Explore further: WHO targets for chronic hepatitis B will be cost-effective

More information: Abstract/Full Text
World Hepatitis Day

Related Stories

WHO targets for chronic hepatitis B will be cost-effective

July 27, 2018
(HealthDay)—Meeting World Health Organization (WHO) targets for chronic hepatitis B by 2030 will be cost-effective, according to a report published in the July issue of Health Affairs.

Availability of generic antivirals for hepatitis B increasing

July 23, 2018
(HealthDay)—Availability of generic antivirals for treating chronic hepatitis B virus (HBV) is increasing, according to research published in the July 20 issue of the U.S. Centers for Disease Control and Prevention's Morbidity ...

One-third of hepatitis C prescriptions receive absolute denial from insurers

July 26, 2018
(HealthDay)—Insurers are increasingly denying prescriptions of direct-acting antiviral (DAA) drugs for hepatitis C virus treatment, according to a study published online June 7 in Open Forum Infectious Diseases.

World Hepatitis Day sets the stage for the elimination of viral hepatitis

July 28, 2017
Today, World Hepatitis Day, marks the first time that the global health community has come together to officially begin moving towards the elimination of viral hepatitis by 2030.

New research: High burden of hepatitis C among people who inject drugs

July 23, 2018
New research: High burden of hepatitis C among people who inject drugs highlights the urgent need for harm reduction and treatment strategies

Cases of hepatitis B and C hit 325 million: WHO

April 21, 2017
An estimated 325 million people are living with hepatitis B or C and few are aware of their condition, with death tolls from the viruses rising, the UN said Friday.

Recommended for you

New hope for cystic fibrosis

October 19, 2018
A new triple-combination drug treatment being trialled at the Mater Hospital in Brisbane could increase the life expectancy of patients with cystic fibrosis.

Bug guts shed light on Central America Chagas disease

October 18, 2018
In Central America, Chagas disease, or American trypanosomiasis, is spread by the "kissing bug" Triatoma dimidiata. By collecting DNA from the guts of these bugs, researchers reporting in PLOS Neglected Tropical Diseases ...

Rapid genomic sequencing of Lassa virus in Nigeria enabled real-time response to 2018 outbreak

October 18, 2018
Mounting a collaborative, real-time response to a Lassa fever outbreak in early 2018, doctors and scientists in Nigeria teamed up with researchers at Broad Institute of MIT and Harvard and colleagues to rapidly sequence the ...

Researchers cure drug-resistant infections without antibiotics

October 17, 2018
Biochemists, microbiologists, drug discovery experts and infectious disease doctors have teamed up in a new study that shows antibiotics are not always necessary to cure sepsis in mice. Instead of killing causative bacteria ...

Infectious disease consultation significantly reduces mortality of patients with bloodstream yeast infections

October 17, 2018
In a retrospective cohort study conducted at the University of Alabama at Birmingham Division of Infectious Diseases, patients with candidemia—a yeast infection in the bloodstream—had more positive outcomes as they relate ...

How drug resistant TB evolved and spread globally

October 17, 2018
The most common form of Mycobacterium tuberculosis (TB) originated in Europe and spread to Asia, Africa and the Americas with European explorers and colonialists, reveals a new study led by UCL and the Norwegian Institute ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.